Interventional Cardiology

This cardiac subspecialty uses minimally invasive, catheter-based technologies in a cath lab to diagnose and treat coronary artery disease (CAD). The main focus in on percutaneous coronary interventions (PCI) to revascularize patients with CAD that is causing blockages resulting in ischemia or myocardial infarction. PCI mainly consists of angioplasty and implanting stents. Interventional cardiology has greatly expanded in scope over recent years to include a number of transcatheter structural heart interventions.

RSS icon
Three patient deaths, 31 injuries and 322 complains led to a U.S. Food and Drug Administration Class 1 recall of Teleflex/Arrow International FiberOptix and UltraFlex intra-aortic balloon pump (IABP) catheter kits in April 2024.

Patient deaths and injuries prompt Teleflex to recall intra-aortic balloon catheters

Three patient deaths, 31 injuries and 322 complaints led to an FDA Class 1 recall of Teleflex/Arrow International intra-aortic balloon pump catheter kits.

Medtronic TAVR valves at heart of multiple sessions during New York cardiology conference

Medtronic’s TAVR technology received a significant amount of attention during the very first New York Valves conference in New York City. Research focused on patients with small annuli as well as how five-year outcomes compare to surgery. 

cardiologist viewing heart data

Edwards shares new data highlighting consistency of its TAVR valves in women, patients with small annuli

Researchers explored five-year data from more than 1,300 TAVR patients treated with a balloon-expandable Sapien 3 valve, sharing their findings at New York Valves 2024: The Structural Heart Summit.

The rapid rise of artificial intelligence (AI) has helped cardiologists, radiologists, nurses and other healthcare providers embrace precision medicine in a way that ensures more heart patients are receiving personalized care.

AI uses imaging results to ID high-risk TAVR patients with speed, accuracy

Researchers developed an advanced AI model capable of extracting measurements from unprocessed CT images in seconds. It then uses those data to evaluate the patient's mortality risk if they underwent TAVR.

Thumbnail

Cardiology salaries keep rising, outpacing consumer prices—interventional cardiologists see biggest jump

Cardiology's gains are far less than some specialties—pay for dermatologists went up more than 10%, for instance—but still ahead of the consumer price index.

money business cash flow dollar

It’s official: Johnson & Johnson completes $13B Shockwave Medical acquisition

The deal, first announced in April, has been finalized. Shockwave will now operate as a business unit within Johnson & Johnson MedTech, and its common stock is no longer trading on NASDAQ.

Thumbnail

Osteosarcopenia linked to much higher risk of death after TAVR—CT screening may prove valuable

Osteosarcopenia, an age-related condition associated with deterioration in the muscles and bones, nearly triples a patient’s risk of dying within one year of undergoing TAVR. 

Richard Heuser, MD, an interventional cardiologist known for his groundbreaking work in the field, leadership and strong business acumen, died on May 23. He was 73 years old.

Cardiologist Richard Heuser, interventional specialist and medical device pioneer, dies at 73

Heuser had a long, impactful career in cardiology. One former colleague said he was “an amazing interventional cardiologist and an even better human being.”

Displaying 425 - 432 of 1260
Design by Adaptive Theme